ACTION group offers solutions various centralized analysis.

Platelet function test

With its numerous analysis devises (Optical aggregometer, Multiplate® analyzer, VerifyNow® ystem, flow cytometry, microplate ELISA, ROTEM®, TEG®) and in partnership with the INSERM UMRS 1166 unit, the ACTION group is in a position to carry out various analyses evaluating the platelet activity.

  • Platelet aggregation measures,
  • Coagulation factor analysis,
  • Receptor expression with measurement of surface proteins,
  • Efficacy measurement of anti-platelet treatment,
  • Measurement of platelet activation on drugs,
  • Measurement of the response variability with VerifyNow.

Related trials : ARCTIC – ANTARCTIC – Private ATLANTIC – AMPHORE – GAMMA – GIANT

Genetics

Through DNA analysis systems (Spartan Rx® et Verigene®) the ACTION group, in partnership with the INSERM UMRS 1166 unit, can propose the genetic profile determination of patients.

  • Identification of genetic variants resistant to anti-platelets,
  • Genes predictive of stent thrombosis,
  • Therapeutic adaptation depending on the genetic profile,
  • Fibrinolyse interaction.

Related studies : ARCTIC-GENE – GIANT – ONASSIST – AMPHORE – GAMMA

Thrombus analysis

  • Structure of the blood clot: physiopathology and pharmacology,
  • Thrombus biology (Transcriptome),
  • Thrombus imaging,
  • Developing and analysis of fibrine clot (density, lyse speed).

Related studies : TIDE – AERE DILATE – PEPCIT

Medical imaging

The ACTION team includes medical experts and specialliy trained personnel, and as a result is able to offer diverse solutions for the analysis of medical imaging.

  • Coronary angiography (TIMI flow, cTFC, TMPG, SYNTAX score, ACC/AHA classification of coronary lesions, etc.),
  • Scanner,
  • Echography,
  • Feasability, training and assistance to centers.

Études liées : ATOLL – EVA-MI – ATLANTIC – ARCTIC – CULPRIT-SHOCK